Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Diabetes--trials, tribulations and pay-off of tight control.

Cranston I, Evans M.

J R Coll Physicians Lond. 1995 Sep-Oct;29(5):431-4.

PMID:
8847690
4.

Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.

Cerveny JD, Leder RD, Weart CW.

Ann Pharmacother. 1998 Sep;32(9):896-905. Review.

PMID:
9762378
5.

[Intensive insulin therapy--is it worth the effort?].

Bürgi U, Villiger L, Diem P.

Ther Umsch. 1995 Oct;52(10):635-8. German.

PMID:
7482373
6.
7.

Insulin therapy in Europe.

Scherbaum WA.

Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S50-6. Review.

PMID:
12324986
8.

Diabetes Control and Complications Trial (DCCT). Update. DCCT Research Group.

[No authors listed]

Diabetes Care. 1990 Apr;13(4):427-33.

PMID:
2180661
9.
10.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
11.

Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.

Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, Mayer I, Rosenbauer J, Wagner C, Zimmermann A, Kerner W, Holl RW; DPV Initiative..

Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):384-8.

PMID:
16915542
12.

Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis.

Egger M, Davey Smith G, Stettler C, Diem P.

Diabet Med. 1997 Nov;14(11):919-28.

PMID:
9400915
13.

Importance of glucose control.

Edelman SV.

Med Clin North Am. 1998 Jul;82(4):665-87. Review.

PMID:
9706116
14.

Treatment of the patient with diabetes: importance of maintaining target HbA(1c) levels.

Davidson JA.

Curr Med Res Opin. 2004 Dec;20(12):1919-27. Review.

PMID:
15701210
15.

Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.

Dunn FL, Nathan DM, Scavini M, Selam JL, Wingrove TG.

Diabetes Care. 1997 Jan;20(1):59-63.

PMID:
9028695
16.

Glucose control guidelines: current concepts.

Barranco JG.

Clin Nutr. 1998 Sep;17 Suppl 2:7-17. Review.

PMID:
10205355
17.

[What allows a type 1 diabetic to be well controlled].

Marre M, Sauvanet JP.

Diabetes Metab. 2002 Sep;28(4 Pt 2):2S7-2S14. Review. French.

18.

Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.

Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM.

Circulation. 2005 May 17;111(19):2446-53.

19.

Are the implications of the Diabetes Control and Complications Trial (DCCT) feasible in daily clinical practice?

Gautier JF, Beressi JP, Leblanc H, Vexiau P, Passa P.

Diabetes Metab. 1996 Dec;22(6):415-9.

PMID:
8985649
20.

[Insulin therapy of Type I diabetes].

Berger W.

Ther Umsch. 1996 Dec;53(12):902-13. German.

PMID:
9036568
Items per page

Supplemental Content

Support Center